Matches in Nanopublications for { ?s ?p "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP364465.RA4DFeddQCPwbqsqtDHogVZEQKvBZGMWA-GWn1WYlQr6k130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364465.RA4DFeddQCPwbqsqtDHogVZEQKvBZGMWA-GWn1WYlQr6k130_provenance.
- NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_provenance.
- NP404375.RAaBslcR29gDhYQ9CFgV-LAZsD7uS0tLdwFBT8NGIxurU130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP404375.RAaBslcR29gDhYQ9CFgV-LAZsD7uS0tLdwFBT8NGIxurU130_provenance.
- assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP618249.RAaGrDVUAWNuRui6DXhhVKI4NEeP29pr3_8CTIyV_fM3c130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618249.RAaGrDVUAWNuRui6DXhhVKI4NEeP29pr3_8CTIyV_fM3c130_provenance.
- NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_provenance.
- NP618251.RAlvvVDR3UAFWsuIcUJ_BnY16oA3g93Hp10CSobRmlZ_4130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618251.RAlvvVDR3UAFWsuIcUJ_BnY16oA3g93Hp10CSobRmlZ_4130_provenance.
- NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_provenance.
- NP618248.RAFdhImkvCDPpxQ433Qi1ZWbv0sxp3KKlNBYI-uvxgR_E130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618248.RAFdhImkvCDPpxQ433Qi1ZWbv0sxp3KKlNBYI-uvxgR_E130_provenance.
- NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_provenance.